Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
E.NavaneethanS
Ethics declarations Competing interests E.M., F.W., J.M.C., M.L.-M., J.V., K.H
Please contact your doctor if you have any questions or concerns regarding your health
News provided by University of Colorado Anschutz Jul 29, 2026, 00:00 ET A study from the University of Colorado Anschutz found that the popular diabetes and weight loss drug reduced heavy drinking and alcohol-related harm in adults with Alcohol Use Disorder AURORA, Colo., July 29, 2026 /PRNewswire/ -- A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with Alcohol Use Disorder (AUD)
